These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 25047104)
1. Clinical course of juvenile myelomonocytic leukemia in the blast crisis phase treated by acute myeloid leukemia-oriented chemotherapy and allogeneic hematopoietic stem cell transplantation. Ueda S; Sakata N; Muramatsu H; Sakaguchi H; Wang X; Xu Y; Kojima S; Yamaguchi T; Higa T; Takemura T Int J Hematol; 2014 Nov; 100(5):502-6. PubMed ID: 25047104 [TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics of 15 children with juvenile myelomonocytic leukaemia who developed blast crisis: MDS Committee of Japanese Society of Paediatric Haematology/Oncology. Honda Y; Tsuchida M; Zaike Y; Masunaga A; Yoshimi A; Kojima S; Ito M; Kikuchi A; Nakahata T; Manabe A Br J Haematol; 2014 Jun; 165(5):682-7. PubMed ID: 24588411 [TBL] [Abstract][Full Text] [Related]
3. [Juvenile myelomonocytic leukemia (JMML): recent advances in molecular pathogenesis and treatment]. Sakashita K Rinsho Ketsueki; 2016 Feb; 57(2):137-46. PubMed ID: 26935631 [TBL] [Abstract][Full Text] [Related]
4. Juvenile myelomonocytic leukemia with PTPN11 mutation in a 23-month-old girl. Jakovljević G; Kardum-Skelin I; Rogosić S; Nakić M Coll Antropol; 2010 Mar; 34(1):251-4. PubMed ID: 20432758 [TBL] [Abstract][Full Text] [Related]
12. Correlation of clinical features with the mutational status of GM-CSF signaling pathway-related genes in juvenile myelomonocytic leukemia. Yoshida N; Yagasaki H; Xu Y; Matsuda K; Yoshimi A; Takahashi Y; Hama A; Nishio N; Muramatsu H; Watanabe N; Matsumoto K; Kato K; Ueyama J; Inada H; Goto H; Yabe M; Kudo K; Mimaya J; Kikuchi A; Manabe A; Koike K; Kojima S Pediatr Res; 2009 Mar; 65(3):334-40. PubMed ID: 19047918 [TBL] [Abstract][Full Text] [Related]
13. Juvenile myelomonocytic leukemia: epidemiology, etiopathogenesis, diagnosis, and management considerations. Yoshimi A; Kojima S; Hirano N Paediatr Drugs; 2010; 12(1):11-21. PubMed ID: 20034338 [TBL] [Abstract][Full Text] [Related]
14. [Allogeneic hematopoietic stem cell transplantation for chronic myelomonocytic leukemia and juvenile myelomonocytic leukemia]. Shao Q; Wang ZD; Zheng XL; Dong L; Han DM; Yan HM; Wang HX; Duan LN Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):1058-62. PubMed ID: 25130828 [TBL] [Abstract][Full Text] [Related]
15. DNA-hypomethylating agents as epigenetic therapy before and after allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes and juvenile myelomonocytic leukemia. Flotho C; Sommer S; Lübbert M Semin Cancer Biol; 2018 Aug; 51():68-79. PubMed ID: 29129488 [TBL] [Abstract][Full Text] [Related]
16. Juvenile myelomonocytic leukaemia presentation after preceding juvenile xanthogranuloma harbouring an identical somatic PTPN11 mutation. Bátai B; Krizsán S; Gángó A; Hegyi L; Csóka M; Erdélyi DJ; Csomor J; Kállay K; Bödör C Pediatr Blood Cancer; 2020 Sep; 67(9):e28368. PubMed ID: 32558336 [No Abstract] [Full Text] [Related]
17. RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia. Lipka DB; Witte T; Toth R; Yang J; Wiesenfarth M; Nöllke P; Fischer A; Brocks D; Gu Z; Park J; Strahm B; Wlodarski M; Yoshimi A; Claus R; Lübbert M; Busch H; Boerries M; Hartmann M; Schönung M; Kilik U; Langstein J; Wierzbinska JA; Pabst C; Garg S; Catalá A; De Moerloose B; Dworzak M; Hasle H; Locatelli F; Masetti R; Schmugge M; Smith O; Stary J; Ussowicz M; van den Heuvel-Eibrink MM; Assenov Y; Schlesner M; Niemeyer C; Flotho C; Plass C Nat Commun; 2017 Dec; 8(1):2126. PubMed ID: 29259247 [TBL] [Abstract][Full Text] [Related]
18. Juvenile myelomonocytic leukemia in the molecular era: a clinician's guide to diagnosis, risk stratification, and treatment. Wintering A; Dvorak CC; Stieglitz E; Loh ML Blood Adv; 2021 Nov; 5(22):4783-4793. PubMed ID: 34525182 [TBL] [Abstract][Full Text] [Related]
19. Bedside to bench in juvenile myelomonocytic leukemia: insights into leukemogenesis from a rare pediatric leukemia. Chang TY; Dvorak CC; Loh ML Blood; 2014 Oct; 124(16):2487-97. PubMed ID: 25163700 [TBL] [Abstract][Full Text] [Related]
20. Transient Myeloproliferative Disorder (TMD), Acute Lymphoblastic Leukemia (ALL), and Juvenile Myelomonocytic Leukemia (JMML) in a Child with Noonan Syndrome: Sequential Occurrence, Single Center Experience, and Review of the Literature. Arrabito M; Li Volsi N; La Rosa M; Samperi P; Pulvirenti G; Cannata E; Russo G; Di Cataldo A; Lo Nigro L Genes (Basel); 2024 Sep; 15(9):. PubMed ID: 39336782 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]